150 related articles for article (PubMed ID: 27116898)
1. Emerging site-specific bioconjugation strategies for radioimmunotracer development.
Massa S; Xavier C; Muyldermans S; Devoogdt N
Expert Opin Drug Deliv; 2016 Aug; 13(8):1149-63. PubMed ID: 27116898
[TBL] [Abstract][Full Text] [Related]
2. Site-specific labeling of cysteine-tagged camelid single-domain antibody-fragments for use in molecular imaging.
Massa S; Xavier C; De Vos J; Caveliers V; Lahoutte T; Muyldermans S; Devoogdt N
Bioconjug Chem; 2014 May; 25(5):979-88. PubMed ID: 24815083
[TBL] [Abstract][Full Text] [Related]
3. Camelid single-domain antibody-fragment engineering for (pre)clinical in vivo molecular imaging applications: adjusting the bullet to its target.
De Vos J; Devoogdt N; Lahoutte T; Muyldermans S
Expert Opin Biol Ther; 2013 Aug; 13(8):1149-60. PubMed ID: 23675652
[TBL] [Abstract][Full Text] [Related]
4. Improving the targeting of therapeutics with single-domain antibodies.
Turner KB; Alves NJ; Medintz IL; Walper SA
Expert Opin Drug Deliv; 2016; 13(4):561-70. PubMed ID: 26689649
[TBL] [Abstract][Full Text] [Related]
5. Sortase A-mediated site-specific labeling of camelid single-domain antibody-fragments: a versatile strategy for multiple molecular imaging modalities.
Massa S; Vikani N; Betti C; Ballet S; Vanderhaegen S; Steyaert J; Descamps B; Vanhove C; Bunschoten A; van Leeuwen FW; Hernot S; Caveliers V; Lahoutte T; Muyldermans S; Xavier C; Devoogdt N
Contrast Media Mol Imaging; 2016 Sep; 11(5):328-339. PubMed ID: 27147480
[TBL] [Abstract][Full Text] [Related]
6. Application Progress of the Single Domain Antibody in Medicine.
Tang H; Gao Y; Han J
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835588
[TBL] [Abstract][Full Text] [Related]
7. Nanobodies as molecular imaging probes.
Barakat S; Berksöz M; Zahedimaram P; Piepoli S; Erman B
Free Radic Biol Med; 2022 Mar; 182():260-275. PubMed ID: 35240292
[TBL] [Abstract][Full Text] [Related]
8. Site-Specifically Labeled Immunoconjugates for Molecular Imaging--Part 2: Peptide Tags and Unnatural Amino Acids.
Adumeau P; Sharma SK; Brent C; Zeglis BM
Mol Imaging Biol; 2016 Apr; 18(2):153-65. PubMed ID: 26754791
[TBL] [Abstract][Full Text] [Related]
9. Antibody-based Radiopharmaceuticals as Theranostic Agents: An Overview.
Sharma R; Suman SK; Mukherjee A
Curr Med Chem; 2022; 29(38):5979-6005. PubMed ID: 35674298
[TBL] [Abstract][Full Text] [Related]
10. Nanobodies and Cancer: Current Status and New Perspectives.
Allegra A; Innao V; Gerace D; Vaddinelli D; Allegra AG; Musolino C
Cancer Invest; 2018 Apr; 36(4):221-237. PubMed ID: 29658806
[TBL] [Abstract][Full Text] [Related]
11. Production of soluble ScFvs with C-terminal-free thiol for site-specific conjugation or stable dimeric ScFvs on demand.
Albrecht H; Burke PA; Natarajan A; Xiong CY; Kalicinsky M; DeNardo GL; DeNardo SJ
Bioconjug Chem; 2004; 15(1):16-26. PubMed ID: 14733579
[TBL] [Abstract][Full Text] [Related]
12. PET Imaging of Macrophage Mannose Receptor-Expressing Macrophages in Tumor Stroma Using 18F-Radiolabeled Camelid Single-Domain Antibody Fragments.
Blykers A; Schoonooghe S; Xavier C; D'hoe K; Laoui D; D'Huyvetter M; Vaneycken I; Cleeren F; Bormans G; Heemskerk J; Raes G; De Baetselier P; Lahoutte T; Devoogdt N; Van Ginderachter JA; Caveliers V
J Nucl Med; 2015 Aug; 56(8):1265-71. PubMed ID: 26069306
[TBL] [Abstract][Full Text] [Related]
13. Site-specific nanobody-oligonucleotide conjugation for super-resolution imaging.
Teodori L; Omer M; Märcher A; Skaanning MK; Andersen VL; Nielsen JS; Oldenburg E; Lin Y; Gothelf KV; Kjems J
J Biol Methods; 2022; 9(1):e159. PubMed ID: 35510035
[TBL] [Abstract][Full Text] [Related]
14. Single-Domain Antibody Theranostics on the Horizon.
Wei W; Younis MH; Lan X; Liu J; Cai W
J Nucl Med; 2022 Oct; 63(10):1475-1479. PubMed ID: 35835579
[TBL] [Abstract][Full Text] [Related]
15. Development and characterization of an αvβ6-specific diabody and a disulfide-stabilized αvβ6-specific cys-diabody.
White JB; Boucher DL; Zettlitz KA; Wu AM; Sutcliffe JL
Nucl Med Biol; 2015 Dec; 42(12):945-57. PubMed ID: 26341848
[TBL] [Abstract][Full Text] [Related]
16. Nanobody Conjugates for Targeted Cancer Therapy and Imaging.
Kang W; Ding C; Zheng D; Ma X; Yi L; Tong X; Wu C; Xue C; Yu Y; Zhou Q
Technol Cancer Res Treat; 2021; 20():15330338211010117. PubMed ID: 33929911
[TBL] [Abstract][Full Text] [Related]
17. RP215 single chain fragment variable and single domain recombinant antibodies induce cell cycle arrest at G0/G1 phase in breast cancer.
Yu F; Wang Y; Xiao Y; He Y; Luo C; Duan D; Li C; Xu S; Xiang T
Mol Immunol; 2014 May; 59(1):100-9. PubMed ID: 24534066
[TBL] [Abstract][Full Text] [Related]
18. Improved biodistribution and radioimmunoimaging with poly(ethylene glycol)-DOTA-conjugated anti-CEA diabody.
Li L; Yazaki PJ; Anderson AL; Crow D; Colcher D; Wu AM; Williams LE; Wong JY; Raubitschek A; Shively JE
Bioconjug Chem; 2006; 17(1):68-76. PubMed ID: 16417253
[TBL] [Abstract][Full Text] [Related]
19. Enhancing Stability of Camelid and Shark Single Domain Antibodies: An Overview.
Goldman ER; Liu JL; Zabetakis D; Anderson GP
Front Immunol; 2017; 8():865. PubMed ID: 28791022
[TBL] [Abstract][Full Text] [Related]
20. A Novel ¹¹¹In-Labeled Anti-Prostate-Specific Membrane Antigen Nanobody for Targeted SPECT/CT Imaging of Prostate Cancer.
Chatalic KL; Veldhoven-Zweistra J; Bolkestein M; Hoeben S; Koning GA; Boerman OC; de Jong M; van Weerden WM
J Nucl Med; 2015 Jul; 56(7):1094-9. PubMed ID: 25977460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
